Gene dosage and pathogenesis of Parkinson's disease

Trends in Molecular Medicine

Volumn 11, Issue 3, 2005, Pages 91-96

  Eriksen, Jason L ^a   Przedborski, Serge ^b   Petrucelli, Leonard ^a  

^a MAYO CLINIC   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CHAPERONE; ISOPROTEIN;

AUTOPHAGY; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; FAMILIAL DISEASE; GENE DOSAGE; GENE DUPLICATION; GENE MUTATION; KNOCKOUT GENE; LYSOSOME; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PROTEIN DEGRADATION; REVIEW; TRANSGENIC MOUSE;

MUS MUSCULUS; PARKINSONIA;

EID: 14844331731     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2005.01.001     Document Type: Short Survey

References (25)

1. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
2. J.L. Eriksen Caught in the act: α-synuclein is the culprit in Parkinson's disease Neuron 40 2003 453 456
3. M.H. Polymeropoulos Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
4. M.G. Spillantini α-Synuclein in Lewy bodies Nature 388 1997 839 840
5. R. Kruger Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
6. J.J. Zarranz The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173
7. A.B. Singleton α-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
8. M.C. Chartier-Harlin α-Synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 2004 1167 1169
9. P. Ibanez Causal relation between α-synuclein gene duplication and familial Parkinson's disease Lancet 364 2004 1169 1171
10. C. Lo Bianco α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 99 2002 10813 10818
11. E. Masliah Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
12. A.M. Cuervo Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy Science 305 2004 1292 1295
13. S. Chandra Double-knockout mice for α- and β-synucleins: effect on synaptic functions Proc. Natl. Acad. Sci. U. S. A. 101 2004 14966 14971
14. M. Farrer Linkage exclusion in French families with probable Parkinson's disease Mov. Disord. 15 2000 1075 1083
15. J.K. Teller Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome Nat. Med. 2 1996 93 95
16. A. West Identification and characterization of the human parkin gene promoter J. Neurochem. 78 2001 1146 1152
17. P. Pals α-Synuclein promoter confers susceptibility to Parkinson's disease Ann. Neurol. 56 2004 591 595
18. A. Massey Pathophysiology of chaperone-mediated autophagy Int. J. Biochem. Cell Biol. 36 2004 2420 2434
19. A.E. Majeski, and J.F. Dice Mechanisms of chaperone-mediated autophagy Int. J. Biochem. Cell Biol. 36 2004 2435 2444
20. Y. Tanaka Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice Nature 406 2000 902 906
21. N. Ostrerova α-Synuclein shares physical and functional homology with 14-3-3 proteins J. Neurosci. 19 1999 5782 5791
22. J. Xu Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease Nat. Med. 8 2002 600 606
23. T.M. Dawson, and V.L. Dawson Rare genetic mutations shed light on the pathogenesis of Parkinson disease J. Clin. Invest. 111 2003 145 151
24. W. Dauer Resistance of α-synuclein null mice to the Parkinsonian neurotoxin MPTP Proc. Natl. Acad. Sci. U. S. A. 99 2002 14524 14529
25. M. Vila, and S. Przedborski Genetic clues to the pathogenesis of Parkinson's disease Nat. Med. 10 Suppl. 2004 S58 S62